HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SU 11654

a tyrosine kinase inhibitor; structure in first source
Also Known As:
SU-11654; SU11654; palladia; toceranib phosphate
Networked: 12 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. London, Cheryl A: 6 articles (01/2013 - 07/2003)
2. Kisseberth, William C: 2 articles (01/2013 - 01/2012)
3. Yancey, M F: 2 articles (04/2010 - 04/2010)
4. Merritt, D A: 2 articles (04/2010 - 04/2010)
5. Chien, May B: 2 articles (04/2006 - 07/2003)
6. Cherrington, Julie M: 2 articles (11/2003 - 07/2003)
7. Williams, L E: 1 article (07/2015)
8. Burton, J H: 1 article (07/2015)
9. Vail, D M: 1 article (07/2015)
10. Axiak-Bechtel, S M: 1 article (07/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Histiocytic Sarcoma
3. Thyroid Neoplasms (Thyroid Cancer)
4. Adenocarcinoma

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. tyrosine receptor (receptor, tyrosine)
3. SU 11654
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
6. masitinib
7. muramylNAc-Ala-isoGln-Lys-tripeptide-PE
8. Lomustine (CCNU)

Related Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)